News Releases

Date	Title and Summary	View
Sep 26, 2019	DePuy Synthes Expands Comprehensive Offering to Treat Degenerative Spine Disease with Launch of 3D Printed Implant Portfolio for Spine Surgery
Sep 24, 2019	Ethicon Launches Industry's First Powered Circular Stapler for Colorectal, Gastric and Thoracic Surgery
Sep 18, 2019	Johnson & Johnson to Host Investor Conference Call on Third Quarter Results NEW BRUNSWICK, N.J. , Sept. 18, 2019 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 15 th to review third-quarter results. Joseph J. Wolk , Executive Vice President, Chief Financial Officer and Christopher
Sep 17, 2019	Janssen to Highlight Depth of Prostate Cancer and Solid Tumor Portfolios with Multiple Data Presentations at ESMO 2019
Sep 17, 2019	U.S. FDA Approves Supplemental New Drug Application (sNDA) for ERLEADA® (apalutamide) for the Treatment of Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Sep 16, 2019	Janssen Submits Application to U.S. FDA Seeking First-in-Class Approval of TREMFYA® (guselkumab) for Treatment of Adults with Active Psoriatic Arthritis
Sep 16, 2019	Johnson & Johnson Vision Introduces TECNIS Synergy™ IOL, a Continuous-Range-of-Vision Intraocular Lens (IOL) at the ESCRS 2019 Congress
Sep 15, 2019	New DARZALEX® (daratumumab) Data from GRIFFIN Study Show High Response Rate and Depth of Response in Patients with Newly Diagnosed Multiple Myeloma Who are Transplant-Eligible
Sep 11, 2019	New Head-to-Head Phase 3 Study Data Show Ponesimod Superiority Versus Aubagio® (teriflunomide) 14 mg in Adults with Relapsing Multiple Sclerosis (MS)
Sep 09, 2019	DePuy Synthes Expands ATTUNE Knee Platform with Cementless Option